DE69913116D1 - Orale flüssige lösung enthaltend das antidepressivum mirtazapine - Google Patents

Orale flüssige lösung enthaltend das antidepressivum mirtazapine

Info

Publication number
DE69913116D1
DE69913116D1 DE69913116T DE69913116T DE69913116D1 DE 69913116 D1 DE69913116 D1 DE 69913116D1 DE 69913116 T DE69913116 T DE 69913116T DE 69913116 T DE69913116 T DE 69913116T DE 69913116 D1 DE69913116 D1 DE 69913116D1
Authority
DE
Germany
Prior art keywords
mirtazapine
antidepressive
solution containing
oral liquid
liquid solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69913116T
Other languages
English (en)
Other versions
DE69913116T2 (de
Inventor
Titus Skrabanja
Edward Tully
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69913116D1 publication Critical patent/DE69913116D1/de
Publication of DE69913116T2 publication Critical patent/DE69913116T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DE69913116T 1998-04-02 1999-03-29 Orale flüssige lösung enthaltend das antidepressivum mirtazapine Expired - Lifetime DE69913116T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98201037 1998-04-02
EP98201037 1998-04-02
PCT/EP1999/002277 WO1999051237A1 (en) 1998-04-02 1999-03-29 Oral liquid antidepressant solution

Publications (2)

Publication Number Publication Date
DE69913116D1 true DE69913116D1 (de) 2004-01-08
DE69913116T2 DE69913116T2 (de) 2004-06-03

Family

ID=8233550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69913116T Expired - Lifetime DE69913116T2 (de) 1998-04-02 1999-03-29 Orale flüssige lösung enthaltend das antidepressivum mirtazapine

Country Status (12)

Country Link
US (2) US6040301A (de)
EP (1) EP1067934B1 (de)
AT (1) ATE254918T1 (de)
AU (1) AU747975B2 (de)
BR (1) BR9909357A (de)
CA (1) CA2326356C (de)
DE (1) DE69913116T2 (de)
DK (1) DK1067934T3 (de)
ES (1) ES2212550T3 (de)
HK (1) HK1032012A1 (de)
PT (1) PT1067934E (de)
WO (1) WO1999051237A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
WO2002064735A2 (en) * 2001-02-12 2002-08-22 Akzo Nobel N.V. Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
WO2006031720A2 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
JP2008519055A (ja) * 2004-11-08 2008-06-05 シャイア エルエルシー ミルタザピンと興奮剤複合物の併用投与の相乗効果
TW200631584A (en) * 2004-11-15 2006-09-16 Akzo Nobel Nv A medicament related to mirtazapine for the treatment of hot flush
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
EP2567069A4 (de) 2010-05-05 2014-04-16 Ener G Rotors Inc Fluidische energieübertragungsvorrichtung
US8714951B2 (en) * 2011-08-05 2014-05-06 Ener-G-Rotors, Inc. Fluid energy transfer device
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
ATE99943T1 (de) * 1989-12-06 1994-01-15 Akzo Nv Psychotropische wirkstoffe enthaltende stabilisierte loesungen.
US5208261A (en) * 1989-12-06 1993-05-04 Akzo N.V. Stabilized solutions of psychotropic agents
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
US5238699A (en) * 1991-11-27 1993-08-24 Kraft General Foods, Inc. Ready-to-eat, low/no-fat puddings and process

Also Published As

Publication number Publication date
EP1067934A1 (de) 2001-01-17
CA2326356C (en) 2008-06-03
WO1999051237A1 (en) 1999-10-14
HK1032012A1 (en) 2001-07-06
DE69913116T2 (de) 2004-06-03
ATE254918T1 (de) 2003-12-15
BR9909357A (pt) 2000-12-12
DK1067934T3 (da) 2004-03-29
AU3604899A (en) 1999-10-25
CA2326356A1 (en) 1999-10-14
PT1067934E (pt) 2004-03-31
ES2212550T3 (es) 2004-07-16
US6040301A (en) 2000-03-21
US6114324A (en) 2000-09-05
EP1067934B1 (de) 2003-11-26
AU747975B2 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
DE69913116D1 (de) Orale flüssige lösung enthaltend das antidepressivum mirtazapine
IS2863B (is) Arípíprazóllausn til gjafar um munn
BR9917007A (pt) Moduladores de ccr5
BR9906758A (pt) Método e composição para transferir zinco para a membrana nasal
FI962494A0 (fi) 5-(2-imidatsolinyyliamino)bentsimidatsolijohdannaisia, niiden valmistus ja niiden käyttö alpha-2-adrenoseptoriagonisteina
RS49609B (sr) Stabilizovani antihistaminski sirup
RS50360B (sr) Farmaceutske formulacije derivata platine
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
NO970051L (no) Vandige risperidon formuleringer
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TR199800585T2 (xx) COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
NO20022201L (no) Lösninger inneholdende Epinastin
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
DK0734261T3 (da) 7-(2-imidazolinylamino)quinolinforbindelser, der er egnede som alfa-2-adrenoceptoragonister
BR9903257A (pt) Concentrado de suspensão aquosa contendo tiadiazurona e etefona
BR9805265A (pt) Sìlicas precipitadas que contêm uma substância ativa.
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
GR1001511B (el) Στεροειδείς συν?έσεις.
DE60128100D1 (de) Analgetisches arzneimittel
DE69521122T2 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
BR9812982A (pt) Agente anti-reumático

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

R082 Change of representative

Ref document number: 1067934

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE